1. Home
  2. CLBT vs ATRC Comparison

CLBT vs ATRC Comparison

Compare CLBT & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$12.12

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$59.17

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
ATRC
Founded
1999
2000
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
CLBT
ATRC
Price
$12.12
$59.17
Analyst Decision
Strong Buy
Buy
Analyst Count
8
10
Target Price
$15.36
★ $55.78
AVG Volume (30 Days)
★ 1.8M
819.5K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 74.74
EPS
N/A
★ 0.18
Revenue
N/A
★ $201,630,000.00
Revenue This Year
$17.03
$13.42
Revenue Next Year
$15.13
$12.12
P/E Ratio
★ $45.29
$329.67
Revenue Growth
N/A
★ 15.40
52 Week Low
$9.58
$25.36
52 Week High
$19.98
$61.70

Technical Indicators

Market Signals
Indicator
CLBT
ATRC
Relative Strength Index (RSI) 60.16 61.37
Support Level $11.65 $26.95
Resistance Level $12.43 $61.70
Average True Range (ATR) 0.38 2.06
MACD 0.13 0.07
Stochastic Oscillator 98.63 95.08

Price Performance

Historical Comparison
CLBT
ATRC

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: